2017-09-06 19:04:55 UTC

AGA's On-Demand Webinars Can Help you Build An Obesity Program

Sept. 6, 2017

Watch these recordings, exclusively for AGA members, to find out how to expertly and efficiently integrate an obesity program into your practice.

The AGA Obesity Practice Guide helps you integrate and operationalize obesity management in your practice for financial success. AGA hosted seven webinars to enhance the Obesity Practice Guide and provide guidance for physicians interested in creating or expanding an obesity management program in their practice. 
 
The webinars covered what to expect, as well as best practices and tips for successfully implementing an obesity program. The recordings are available for AGA members only in the AGA Community resource library:
  1. AGA Solutions to Successful Obesity Program Integration
  2. Intro to the AGA Episode of Care for Obesity          
  3. Incorporating Pharmaceuticals and Medication Management      
  4. Incorporating Nutritional Counseling          
  5. Incorporating Behavioral Consultation       
  6. Lessons from a Large GI Group
  7. Lessons from a Solo GI Practitioner
Login and view the full list of recordings. If you have questions about obesity management and how to begin, you can post them in the forum for Drs. Streett and Acosta. 
 
We’re also interested in hearing your challenges and successes in implementing an obesity program in your practice. Share your experience with the community. 

More on Obesity

Blog: Restricting Fructose to Reduce Fatty Liver Disease

Sept. 19, 2017

Researchers report that reducing dietary fructose decreases liver fat in children with obesity and metabolic syndrome. Read more in the AGA Journals blog.

Image Challenge: Complaints of Dysphagia and Heartburn After Bariatric Surgeries?

Sept. 6, 2017

The patient had an adjustable gastric band migrate, Roux-en-Y gastric bypass fail and a supportive band placed on the gastric pouch fail.

FDA Issues Alert for Liquid-Filled Intragastric Balloon Systems

Aug. 11, 2017

Providers encouraged to report all adverse events to the FDA.